Dr. Melanie Pickett, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,872 | 392 | 87.3% |
| Consulting Fee | $800.00 | 1 | 10.2% |
| Education | $198.99 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Almirall LLC | $945.42 | 3 | $0 (2021) |
| Janssen Biotech, Inc. | $823.81 | 61 | $0 (2024) |
| MAYNE PHARMA INC. | $713.91 | 55 | $0 (2021) |
| Galderma Laboratories, L.P. | $581.77 | 27 | $0 (2024) |
| ABBVIE INC. | $577.74 | 19 | $0 (2024) |
| GENZYME CORPORATION | $557.00 | 24 | $0 (2024) |
| LEO Pharma Inc. | $469.84 | 22 | $0 (2024) |
| VYNE Pharmaceuticals Inc. | $457.96 | 30 | $0 (2021) |
| UCB, Inc. | $311.98 | 19 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $277.87 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $992.90 | 45 | Amgen Inc. ($141.87) |
| 2023 | $603.32 | 27 | Novartis Pharmaceuticals Corporation ($87.13) |
| 2022 | $321.34 | 18 | Janssen Biotech, Inc. ($63.08) |
| 2021 | $1,685 | 61 | Almirall LLC ($800.00) |
| 2020 | $1,405 | 102 | VYNE Pharmaceuticals Inc. ($328.38) |
| 2019 | $2,328 | 116 | Mayne Pharma Inc. ($346.05) |
| 2018 | $536.45 | 26 | Mayne Pharma Inc. ($159.95) |
All Payment Transactions
395 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.17 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Dermatology | ||||||
| 11/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.84 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: DERMATOLOGY | ||||||
| 10/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $21.34 | General |
| 09/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Dermatology | ||||||
| 07/15/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $30.52 | General |
| Category: Wound Care | ||||||
| 05/31/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 05/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Inflammation | ||||||
| 05/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: DERMATOLOGY | ||||||
| 05/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: DERMATOLOGY | ||||||
| 05/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Dermatology | ||||||
| 04/30/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $28.37 | General |
| 04/24/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 446 | 927 | $105,849 | $35,900 |
| 2022 | 9 | 374 | 731 | $98,669 | $27,861 |
| 2021 | 9 | 365 | 678 | $123,822 | $29,373 |
| 2020 | 9 | 325 | 560 | $100,468 | $20,839 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 200 | $36,842 | $12,957 | 35.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 83 | 127 | $17,746 | $5,210 | 29.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 54 | 67 | $14,301 | $4,763 | 33.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 32 | 44 | $10,523 | $3,691 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 23 | $5,981 | $2,081 | 34.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 59 | 385 | $5,427 | $2,004 | 36.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 25 | $5,698 | $1,895 | 33.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 13 | $4,591 | $1,556 | 33.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 16 | 23 | $2,427 | $951.45 | 39.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 20 | $2,313 | $790.85 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 155 | $32,047 | $9,852 | 30.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 50 | 59 | $15,752 | $4,170 | 26.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 35 | 44 | $13,116 | $3,825 | 29.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 65 | 90 | $15,286 | $3,405 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $6,160 | $1,729 | 28.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 48 | 300 | $4,989 | $1,657 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 20 | $6,098 | $1,605 | 26.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 15 | 25 | $3,286 | $1,067 | 32.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 15 | $1,934 | $550.88 | 28.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 105 | 162 | $41,484 | $10,602 | 25.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 45 | 54 | $17,355 | $3,825 | 22.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 67 | 87 | $17,841 | $3,424 | 19.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 30 | 39 | $13,872 | $3,366 | 24.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 33 | 33 | $11,179 | $2,521 | 22.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 22 | $8,220 | $1,868 | 22.7% |
About Dr. Melanie Pickett, MD
Dr. Melanie Pickett, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2014. The National Provider Identifier (NPI) number assigned to this provider is 1407274996.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melanie Pickett, MD has received a total of $7,871 in payments from pharmaceutical and medical device companies, with $992.90 received in 2024. These payments were reported across 395 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,872).
As a Medicare-enrolled provider, Pickett has provided services to 1,510 Medicare beneficiaries, totaling 2,896 services with total Medicare billing of $113,972. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Dermatology
- Location Austin, TX
- Active Since 04/01/2014
- Last Updated 01/18/2019
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1407274996
Products in Payments
- Klisyri (Drug) $800.00
- DORYX (Drug) $653.95
- TREMFYA (Drug) $563.55
- DUPIXENT (Biological) $367.01
- ENSTILAR (Drug) $285.52
- AMZEEQ (Drug) $256.71
- EPIDUO FORTE (Drug) $251.49
- Cimzia (Drug) $242.36
- TALTZ (Drug) $241.73
- Otezla (Drug) $237.82
- EUCRISA (Drug) $233.35
- Humira (Biological) $220.12
- ZILXI (Drug) $201.25
- DUPIXENT (Drug) $182.50
- REMICADE (Biological) $161.26
- Skyrizi (Biological) $152.59
- Seysara (Drug) $145.42
- ILUMYA (Biological) $110.24
- Sotyktu (Drug) $109.53
- SOOLANTRA (Drug) $103.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Austin
Raimy Amasha, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $49,061
Dr. Jose Romero, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $42,986
Erik Krause, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $27,736
Dr. Gregory Catlett, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $24,455
Sara Pavitt
Student in an Organized Health Care Education/Training Program — Payments: $23,230
Dr. Elizabeth Foley, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $17,688